Replies to post #3954 on Kaleidoscope Venture Capital, Inc. (fka KLDO)

[ErnieBilco]

On April 8, 2021, Kaleido Biosciences, Inc. (the “Company”) delivered formal notice to The Nasdaq Stock Market, Inc. that the Company intends to
voluntarily delist its common stock, par value $0.001 per share (the “Common Stock”), from the Nasdaq Global Select Stock Market (“Nasdaq”) in
connection with the Company’s cessation of all operations